Reply: Placebo drift, dose heterogeneity, and the winner’s curse—Re-evaluating the hierarchy of MASH therapeutics

Hepatology 2026

View at publisher

Authors: MATHEUS MARCOS XAVIER DE SOUZA, Daniel Q. Huang, Rohit Seth Loomba

DOI: 10.1097/hep.0000000000001673

Cited by: 0

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Hepatitis C virus research Alcohol Consumption and Health Effects